Matthew Farabaugh, based in Philadelphia, PA, US, is currently a Chief Financial Officer at SK pharmteco, bringing experience from previous roles at Center for Breakthrough Medicines, Coalition of Cancer Cooperative Groups, WuXi Advanced Therapies and University of Pennsylvania. Matthew Farabaugh holds a 2007 - 2009 Master’s Degree in Molecular Biotechnology @ University of Pennsylvania. With a robust skill set that includes Oncology, Infectious Diseases, Clinical Trials, Clinical Research, Gene Therapy and more, Matthew Farabaugh contributes valuable insights to the industry. Matthew Farabaugh has 5 emails and 1 mobile phone number on RocketReach.